| Literature DB >> 29403813 |
Chien C Wang1, Roxana A Gómez1,2, Liliana P Fernandez1,3.
Abstract
The illicit addition of phosphodiesterase type-5 (PDE-5) inhibitors like sildenafil (Viagra) in product offered as herbal medicine or dietary supplement for male erectile dysfunction has concerned authorities in recent times. In this paper, we proposed a sensitive surfactant-coated Amberlite XAD™ resin for sildenafil preconcentration method with spectrofluorimetric detection. Retention capacity of micellar coated XAD resin for sildenafil was studied and the obtained eluate was measured by spectrofluorometer at excitation and emission wavelengths of 350 and 430 nm, respectively. This method allowed the detection of sildenafil at 0.15 ng/mL with linear range of 0.0003-7.0 μg/mL. The method has been successfully applied to the analysis of some local commercially available herbal medicines and urine.Entities:
Keywords: Herbal medicines; Sildenafil; Spectrofluorimetric analysis; Surfactant
Year: 2012 PMID: 29403813 PMCID: PMC5760990 DOI: 10.1016/j.jpha.2012.11.001
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Comparison of reported methods for sildenafil determination.
| Method | Detection system | Linearity range (μg/mL) | LOD (μg/mL) | Reference |
|---|---|---|---|---|
| Extractive spectrophotometric method | UV–visible spectrophotometry | Method A 1.25–25 | 0.16 | |
| Method B1.5–60 | 0.18 | |||
| HPLC | UV–visible spectrophotometry | 0.01–1 | No available | |
| Micellar electrokinetic chromatography | UV–visible spectrophotometry | 0.080–0.9 | 0.017 | |
| HPLC-MS | Electrospray positive ionization (ESI) mass-spectrometry | 0.000125–0.04 | 0.00005 | |
| Adsorptive stripping square-wave voltammetry | Voltammetry | 0.029–0.32 | No available | |
| Polymer membrane sensors | Potentiometry | 6.6–600 | 3.3 | |
| Surfactant-mediated spectrofluorimetry | Spectrofluorimetry | Method A 0.004–25 | 0.0012 | |
| Method B 0.005–50 | 0.0016 | |||
| Present method | Spectrofluorimetry | 0.0003–7 | 0.00015 | – |
Fig. 1Schematic representation of the preconcentration step in XAD column.
Fig. 2(A) Fluorescence emission of sildenafil–HTAB. (B) Determination of CMC for HTAB–sildenafil system. (A) Spectra of sildenafil in the absence and presence of HTAB; Csildenafil=40 μg/mL; CHTAB (mM): I=0.00, II=0.40, III=0.60, IV=1.00. (B) Sildenafil fluorescence at increasing concentration of HTAB; Csildenafil=40 μg/mL;
Fig. 3Influence of pH on sildenafil–HTAB interaction CSildenafil=5 μg/mL.
Fig. 4Emission spectra of sildenafil before and after preconcentration. Csildenafil=5 μg/mL where: (a) before preconcentration step and (b) after preconcentration step (initial volume=200 mL).
Analytical parameters and figures of merit of different optical methodologies for sildenafil determination.
| Analytical parameters | UV–vis photometry | HTAB-mediated fluorimetry | This methodology |
|---|---|---|---|
| 225 | |||
| Linearity range (μg/mL) | 5.6–50.0 | (0.004–25) | (0.0003–7) |
| Slope | 0.0441 | 67.50 | 655.20 |
| Intercept | 0.03 | 45.47 | 30.11 |
| Correlation coefficient | 0.997 | 0.998 | 0.990 |
| LOQ (μg/mL) | 5.60 | 0.004 | 0.0003 |
| LOD (μg/mL) | 1.76 | 0.0012 | 0.00015 |
Recovery study for sildenafil in real samples of herbal medicines.
| Samples | Added (μg/mL) | Found (μg/mL) | RSD (%) | Recovery (%) |
|---|---|---|---|---|
| 0.250 | 0.248 | ±2.7 | 99.2 | |
| 0.500 | 0.505 | ±2.5 | 101.0 | |
| 0.750 | 0.754 | ±2.1 | 100.5 | |
| 1.000 | 1.010 | ±1.4 | 96.2 99.6 | |
| 1.250 | 1.245 | ±1.6 | ||
| 1.500 | 1.502 | ±0.9 | 100.1 | |
| Extract of mixture herbals | 0.250 | 0.251 | ±3.1 | 100.4 |
| 0.500 | 0.501 | ±1.9 | 100.2 | |
| 0.750 | 0.749 | ±2.0 | 99.8 | |
| 1.000 | 1.009 | ±1.1 | 100.9 | |
| 1.250 | 1.241 | ±1.9 | 99.3 | |
| 1.500 | 1.509 | ±2.0 | 100.6 | |
| Urine | 0.250 | 0.260 | ±2.8 | 104.0 |
| 0.500 | 0.521 | ±1.2 | 104.2 | |
| 0.750 | 0.756 | ±1.1 | 100.8 | |
| 1.000 | 1.012 | ±1.0 | 101.2 | |
| 1.250 | 1.251 | ±1.3 | 100.0 | |
| 1.500 | 1.514 | ±2.1 | 100.9 | |
Average of 6 replicates.